CDKN2A and exocrine pancreatic carcinoma: Previously, diagnostic accuracy of some biomarkers such as K-ras analysis for pancreatic carcinoma has been shown to be diverse in different samples;28 therefore, we stratified the analysis of CDKN2A methylation by specimen types (blood, pancreatic tissue and pancreatic juice) for pancreatic carcinoma.